Cargando…
FDA’s new pharmaceutical quality initiative: Knowledge-aided assessment & structured applications
This paper describes a new FDA’s pharmaceutical quality assessment system: Knowledge-aided Assessment & Structured Application (KASA). The KASA system is designed to: 1) capture and manage knowledge during the lifecycle of a drug product; 2) establish rules and algorithms for risk assessment, co...
Autores principales: | Yu, Lawrence X., Raw, Andre, Wu, Larisa, Capacci-Daniel, Christina, Zhang, Ying, Rosencrance, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733282/ https://www.ncbi.nlm.nih.gov/pubmed/31517275 http://dx.doi.org/10.1016/j.ijpx.2019.100010 |
Ejemplares similares
-
The effects of lobbying on the FDA’s recall classification
por: Zhou, Yifan
Publicado: (2023) -
Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022) -
Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative
por: Mooghali, Maryam, et al.
Publicado: (2023) -
A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA’s Sentinel Initiative
por: Brown, Joshua D.
Publicado: (2020) -
LAWS, REGULATIONS, AND POLICY: Genetically Engineered Salmon on the FDA’s Table
por: Taylor, David A.
Publicado: (2010)